AURKB, CHEK1 and NEK2 as the Potential Target Proteins of Scutellaria barbata on Hepatocellular Carcinoma: An Integrated Bioinformatics Analysis

被引:10
|
作者
Huang, Chaoyuan [1 ]
Luo, Hu [1 ]
Huang, Yuancheng [1 ]
Fang, Chongkai [1 ]
Zhao, Lina [2 ]
Li, Peiwu [2 ]
Zhong, Chong [3 ]
Liu, Fengbin [2 ,4 ]
机构
[1] Guangzhou Univ Chinese Med, Clin Med Sch 1, Guangzhou, Peoples R China
[2] Guangzhou Univ Chinese Med, Dept Gastroenterol, Affiliated Hosp 1, Guangzhou, Peoples R China
[3] Guangzhou Univ Chinese Med, Dept Hepatobiliary Surg, Affiliated Hosp 1, Guangzhou, Peoples R China
[4] Guangzhou Univ Chinese Med, Dept Gastroenterol, Baiyun Hosp, Affiliated Hosp 1, Guangzhou, Peoples R China
来源
INTERNATIONAL JOURNAL OF GENERAL MEDICINE | 2021年 / 14卷
基金
中国国家自然科学基金;
关键词
Scutellaria barbata; hepatocellular carcinoma; effector mechanism; network pharmacology; bioinformatics analysis; molecular docking; DIFFERENTIALLY EXPRESSED GENES; CELL-CYCLE REGULATION; KINASE; CANCER; PATHWAYS; SPINDLE;
D O I
10.2147/IJGM.S318077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We aim to explore the potential anti-HCC mechanism of Scutellaria barbata through integrated bioinformatics analysis. Methods: We searched active ingredients and related targets of Scutellaria barbata via TCMSP database, PubChem and SwissTargetPrediction database. Then, we identified HCC disease targets from GEO dataset by WGCNA. Next, the intersected targets of disease targets and drug targets were input into STRING database to construct PPI networking in order to obtain potential therapeutic targets of Scutellaria barbata. Cytoscape software was used to carry out network topology analysis of potential targets. We used the R package for GO analysis and KEGG analysis. Finally, we used AutoDock vina and PyMOL software for molecular docking. Results: Sixteen active components from Scutellaria barbata were lastly selected for further investigation. A total of 442 component targets were identified from 16 active ingredients of Scutellaria barbata after the removal of duplicate targets. GSE45436 was selected for construction of WGCNA and screening of differentially expressed genes. A total of 354 genes were up-regulated in HCC samples and 100 were down-regulated in HCC patients. Twenty-one common genes were obtained by intersection and 10 critical targets were filtered for further investigation. The enrichment analysis showed that cell cycle, DNA replication, p53 signaling pathway were mainly involved. The molecular docking results showed that 4 potential combinations were with the best binding energy and molecular interactions. Conclusion: AURKB, CHEK1 and NEK2 could be the potential target proteins of Scutellaria barbata in treating HCC. Cell cycle, DNA replication, p53 signaling pathway consist of the fundamental regulation cores in this mechanism.
引用
收藏
页码:3295 / 3312
页数:18
相关论文
共 50 条
  • [41] Integrated analysis of ceRNA network reveals potential prognostic Hint1-related lncRNAs involved in hepatocellular carcinoma progression
    Cheng Zhang
    Tianhao Bao
    Yang Ke
    Xin Liu
    Xinghong Wang
    Weiran Liao
    Yutao He
    Lin Wang
    World Journal of Surgical Oncology, 20
  • [42] Integrated analysis of ceRNA network reveals potential prognostic Hint1-related lncRNAs involved in hepatocellular carcinoma progression
    Zhang, Cheng
    Bao, Tianhao
    Ke, Yang
    Liu, Xin
    Wang, Xinghong
    Liao, Weiran
    He, Yutao
    Wang, Lin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [43] Integrative Transcriptomic, Proteomic and Functional Analysis Reveals ATP1B3 as a Diagnostic and Potential Therapeutic Target in Hepatocellular Carcinoma
    Lu, Shanshan
    Cai, Shenglan
    Peng, Xiaozhen
    Cheng, Ruochan
    Zhang, Yiya
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [44] Comprehensive analysis identifies long non-coding RNA RNASEH1-AS1 as a potential prognostic biomarker and oncogenic target in hepatocellular carcinoma
    Sun, Jin
    Li, Yingnan
    Tian, Hongwei
    Chen, Haiyan
    Li, Jun
    Li, Zongfang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (03):
  • [45] Integrated analysis of tumor and adjacent non-tumor proteomic data reveals SERPINH1 as a recurrence biomarker and drug target in hepatocellular carcinoma
    Hou, Yushan
    Zhang, Yiming
    Zheng, Kun
    Wang, Han
    Zhou, Yingying
    Zhai, Yuanjun
    He, Fuchu
    Tian, Chunyan
    Sun, Aihua
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2024, 20 (13): : 5191 - 5207
  • [46] E2F1-driven EXOSC10 transcription promotes hepatocellular carcinoma growth and stemness: a potential therapeutic target
    Haoyue Deng
    Dingyong Wu
    Yongpeng He
    Xiaolei Yu
    Jifei Liu
    Yanrui Zhang
    Bing Leng
    Xiaofeng Yuan
    Liguo Xiao
    Hereditas, 162 (1)
  • [47] Proteins S100A8 and S100A9 are potential biomarkers for renal cell carcinoma in the early stages: Results from a proteomic study integrated with bioinformatics analysis
    Zhang, Limin
    Jiang, Haowen
    Xu, Gang
    Wen, Hui
    Gu, Bin
    Liu, Jun
    Mao, Shanghua
    Na, Rong
    Jing, Yan
    Ding, Qiang
    Zhang, Yuanfang
    MOLECULAR MEDICINE REPORTS, 2015, 11 (06) : 4093 - 4100
  • [48] Deciphering the immunological and prognostic features of hepatocellular carcinoma through ADP-ribosylation-related genes analysis and identify potential therapeutic target ARFIP2
    Jiang, Fenfen
    Xu, Yan
    Jiang, Zhuang
    Hu, Bin
    Lv, Qing
    Wang, Zhiyong
    CELLULAR SIGNALLING, 2024, 117
  • [49] Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic target
    Huang, Tai-Chung
    Cutler, Jevon
    Bharne, Shubhada
    Zhong, Jun
    Weinstock, David
    Tyner, Jeffrey
    Gojo, Ivana
    Civin, Curt
    Pandey, Akhilesh
    LEUKEMIA & LYMPHOMA, 2015, 56 (05) : 1524 - 1527
  • [50] Somatic genomic alterations TP53, CDKN2A, ATM, EPHA7, POT1, CHEK1, GRIN2A and EGFR worsen survival in penile squamous cell carcinoma: comprehensive DNA analysis of 146 cases and correlation with patient's follow-up
    Hrudka, J.
    Hojny, J.
    Prouzova, Z.
    Krkavcova, E.
    Bartu, M. Kendall
    Dvorak, J.
    Michalkova, R.
    Capka, D.
    Zavillova, N.
    Matej, R.
    Waldauf, P.
    VIRCHOWS ARCHIV, 2024, 485 : S41 - S41